Abstract: An actuator arrangement comprises an actuator having a rotatable drive input, a motor, and a drive transmission arrangement for transmitting rotary drive from the motor to the rotatable drive input of the actuator, wherein the transmission arrangement includes a telescopic drive coupling.

Abstract: A child-resistant package includes a support for supporting hazardous material in use; a structure for selectively blocking access to hazardous material supported by the support, with the support being movable between a secured position in which access to the hazardous material is blocked and an access position in which the hazardous material is accessibly clear of the structure; at least one latch member movable between an engaged state and a disengaged state in which the support is allowed to move out of the secured position toward the access position; and a tab member movable with respect to the structure in a second direction different to the first direction, the tab member being coupled to the support to effect movement of the support out of the secured position in the first direction when the latch member is in the disengaged state.

Abstract: Child-resistant packages and components thereof are disclosed.

Abstract: The present invention relates to the use of nitric oxide-releasing statins of formula (I) for the treatment of pulmonary arterial hypertension.

Abstract: An actuator arrangement comprises an actuator having a rotatable drive input, a motor, and a drive transmission arrangement for transmitting rotary drive from the motor to the rotatable drive input of the actuator, wherein the transmission arrangement includes a telescopic drive coupling.

Abstract: A memory accelerator module buffers program instructions and/or data for high speed access using a deterministic access protocol. The program memory is logically partitioned into ‘stripes’, or ‘cyclically sequential’ partitions, and the memory accelerator module includes a latch that is associated with each partition. When a particular partition is accessed, it is loaded into its corresponding latch, and the instructions in the next sequential partition are automatically pre-fetched into their corresponding latch. In this manner, the performance of a sequential-access process will have a known response, because the pre-fetched instructions from the next partition will be in the latch when the program sequences to these instructions. Previously accessed blocks remain in their corresponding latches until the pre-fetch process ‘cycles around’ and overwrites the contents of each sequentially-accessed latch.

Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the treatment of chronic inflammatory disease states.